NCT01794845 Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma Status TERMINATED Phase PHASE2
NCT01770002 Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved? Status COMPLETED Phase NA
NCT01760811 CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT Status UNKNOWN Phase PHASE1/PHASE2
NCT01755650 Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies Status TERMINATED Phase EARLY_PHASE1
NCT01666431 Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment Status TERMINATED Phase PHASE2
NCT01631357 Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT01592721 Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT01586767 Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy Status ACTIVE_NOT_RECRUITING Phase NA
NCT01561456 Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung Status COMPLETED Phase PHASE2
NCT01540695 Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology Status COMPLETED Phase N/A
NCT01484769 Method Development and Assessment of the Effects of Tobacco Products on Oral Cavity Cells Status WITHDRAWN Phase N/A
NCT01363466 Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer Status TERMINATED Phase PHASE3
NCT01333852 Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT01298167 Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery Status COMPLETED Phase NA
NCT01265472 Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic Malignancy Status UNKNOWN Phase N/A
NCT01232374 Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT01211938 Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract Status COMPLETED Phase PHASE2/PHASE3